{"name":"Nicola Longo","slug":"nicola-longo","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPdE81R0RUNG93MjNnSWllQTM5WWF0a2dxdXRGekRKb2o3V0hhUm1Tc3B4Zm1la0xJQnhKT2I2bjJKRFhHRFpUdU5seHlOOU1UdWIzZ2JfNG0yY1BTaUNPbE5Bak1zeC13c2xzX1JrX0t0UEJ0WVl5ZHEwaHFfOXF0ZE45LUt4aTdTeUN1OVkzWElmUnVOeUJXbkhHc1VybkM2azFJUnY4V2YxQQ?oc=5","date":"2021-11-05","type":"pipeline","source":"University of Utah Health","summary":"U of U Health Designated as Rare Disease Center for Excellence - University of Utah Health","headline":"U of U Health Designated as Rare Disease Center for Excellence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPaUFVaERVNVpUMFFhNG02VkxnVHloV0FOMXZOa2drN255eTMxRWMtWXlsenpzQ3lNUGZUcF9hM1BueUZLNWhiNlV3aS1HN3dWSmhEQXBTVzROSHptM01zeHZxd2hSa2RZRHNOb1Izb1dNVF96aGtJNHZ6TXR3WnJQQks3M1JaNFVHRzQ4blpaTFdxZlRaVUFGcU0xc01CaGdUQzZMWg?oc=5","date":"2018-12-28","type":"regulatory","source":"Medical Professionals Reference","summary":"Ravicti Approved for Children Under 2 Months With Urea Cycle Disorders - Medical Professionals Reference","headline":"Ravicti Approved for Children Under 2 Months With Urea Cycle Disorders","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE8wLU1mOFpvLXRLWThCdVdPa0xQVHJqampQQ0lFUTFnTVlPZDYycTN4R0cwYnBGYkc0bTJPTUNzWUN6VFRsZGdrRFE0amszU3dpNXVtLQ?oc=5","date":"2014-09-18","type":"pipeline","source":"Nature","summary":"Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year analysis of safety and efficacy - Nature","headline":"Long-term developmental progression in infants and young children taking sapropterin for phenylketonuria: a two-year ana","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}